Camille L Bedrosian Amylyx Pharmaceuticals, Inc. (AMLX) insider trading activity

Camille L Bedrosian is Chief Medical Officer of Amylyx Pharmaceuticals, Inc.. Currently has a direct ownership of 143,801 shares of AMLX, which is worth approximately $713,252. The most recent transaction as insider was on Sep 30, 2024, when has been sold 11,442 shares (Common Stock) at a price of $3.2 per share, resulting in proceeds of $36,614. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 144K

7.37% 3M change

n/a 12M change

Total Value Held $713,252

Camille L Bedrosian Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	SELL Open market or private sale	$36,614 $3.2 p/Share	11,442 Reduced 7.37%	143,801 Common Stock
Apr 16 2024	BUY Grant, award, or other acquisition	-	96,910 Added 38.43%	155,243 Common Stock
Nov 27 2023	BUY Grant, award, or other acquisition	-	58,333 Added 50.0%	58,333 Common Stock

Also insider at

CRNX

Crinetics Pharmaceuticals, Inc. Healthcare

RARE

Ultragenyx Pharmaceutical Inc. Healthcare

EVP and Chief Medical Officer

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

Director

CLB